Terms: = Lung cancer AND PICALM, CLTH, 8301, ENSG00000073921, CALM, Q13492 AND Treatment
5 results:
1. Effectiveness of structured psycho-oncological counseling for relatives of lung cancer patients based on the calm approach-study protocol of a randomized controlled trial.
Dusel J; Meng K; Arnold H; Rabe A; Jentschke E
Trials; 2024 Feb; 25(1):115. PubMed ID: 38336739
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of Managing cancer and Living Meaningfully (calm) in people with advanced non-small cell lung cancer treated with immunotherapies or targeted therapies: protocol for a single-arm, mixed-methods pilot study.
Lynch FA; Rodin G; Jefford M; Duffy M; Lai-Kwon J; Heynemann S; Mileshkin L; Briggs L; Burke J; Leigh L; Spelman T; Ftanou M
BMJ Open; 2023 Jul; 13(7):e072322. PubMed ID: 37524546
[TBL] [Abstract] [Full Text] [Related]
3. Effects of calm intervention on neutrophil-to-lymphocyte ratio (NLR), fear of cancer recurrence and quality of life in patients with lung cancer.
Zhao J; Wang M; Huang R; Xu J; Gan C; Yu S; Tang L; Yao S; Li W; Cheng H
Support Care Cancer; 2023 Jul; 31(7):447. PubMed ID: 37414980
[TBL] [Abstract] [Full Text] [Related]
4. Reducing Anxiety and Dyspnea via Device-Guided Breathing (RELAX): A Multi-Site Feasibility Study in Post-treatment lung cancer Survivors at Community cancer Clinics (WF-01213).
Danhauer SC; Dressler EV; Brown WM; Nightingale CL; Brenes GA; Petty WJ; Curtis A; Murkutla S; Huang J; Wagi CR; Lesser GJ; Weaver KE
Integr Cancer Ther; 2023; 22():15347354231164406. PubMed ID: 37029555
[TBL] [Abstract] [Full Text] [Related]
5. Combinational Analysis of FISH and Immunohistochemistry Reveals Rare Genomic Events in ALK Fusion Patterns in NSCLC that Responds to Crizotinib treatment.
Li W; Zhang J; Guo L; Chuai S; Shan L; Ying J
J Thorac Oncol; 2017 Jan; 12(1):94-101. PubMed ID: 27614248
[TBL] [Abstract] [Full Text] [Related]
